'M-vix' to debut in October

Published: 2007-09-06 06:59:00

Updated: 2007-09-06 06:59:00

SK Chemicals said on September 3 that the company is planning to begin selling its anti-impotence medication M-vix (mirodenafil HCl) in October as the Korea Food and Drug Administration plans to enact a bill to designate the drug as one of the controlled drugs by September 20.

The KFDA approve...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK